<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: Individuals with the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> (MS), a clustering of risk factors [<z:chebi fb="4" ids="17855">triglycerides</z:chebi>, <z:chebi fb="105" ids="17234">glucose</z:chebi>, <z:chebi fb="1" ids="47775">high-density lipoprotein cholesterol</z:chebi>, blood pressure (BP), abdominal <z:hpo ids='HP_0001513'>obesity</z:hpo>] defined by the National Cholesterol Education Program (NCEP), are at high risk for <z:e sem="disease" ids="C0010068" disease_type="Disease or Syndrome" abbrv="">coronary heart disease</z:e> and type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo>, and may benefit from aggressive lifestyle modification </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: We reviewed 1 year of consecutive patients' charts to determine the prevalence of the MS in <z:mp ids='MP_0001261'>obese</z:mp> individuals enrolled in a medically supervised rapid <z:hpo ids='HP_0001824'>weight loss</z:hpo> programme, the correlation of weight change with the components of the MS, and response to diet-induced <z:hpo ids='HP_0001824'>weight loss</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: Out of 185 individuals, 125 (68%) met the NCEP definition of the MS </plain></SENT>
<SENT sid="3" pm="."><plain>A moderate decrease in weight (6.5%) induced by a very low calorie diet (VLCD) resulted in substantial reductions of systolic (11.1 mmHg) and diastolic (5.8 mmHg) blood pressure (BP), <z:chebi fb="105" ids="17234">glucose</z:chebi> (17 mg/dl), <z:chebi fb="4" ids="17855">triglycerides</z:chebi> (94 mg/dl) and total cholesterol (37 mg/dl) at 4 weeks (<z:hpo ids='HP_0000001'>all</z:hpo> p &lt; 0.001) </plain></SENT>
<SENT sid="4" pm="."><plain>These improvements were sustained at the end of active <z:hpo ids='HP_0001824'>weight loss</z:hpo> (average 16.7 weeks; total <z:hpo ids='HP_0001824'>weight loss</z:hpo> 15.1%), with further significant reductions in BP and <z:chebi fb="4" ids="17855">triglycerides</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0001824'>Weight loss</z:hpo> was related to the changes in each criterion of the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: The MS is prevalent in two-thirds of <z:mp ids='MP_0001261'>obese</z:mp> individuals enrolling in a structured <z:hpo ids='HP_0001824'>weight loss</z:hpo> programme </plain></SENT>
<SENT sid="7" pm="."><plain>Moderate <z:hpo ids='HP_0001824'>weight loss</z:hpo> with a VLCD markedly improved <z:hpo ids='HP_0000001'>all</z:hpo> aspects of the MS </plain></SENT>
</text></document>